Myositis Patient Video Support Session, March 16th. Session is tailored to those diagnosed with or suspected of having Polymyositis,...
Myositis Patient Video Support Session, March 6th. Session is tailored to those diagnosed with or suspected of having Polymyositis,...
Myositis Patient Video Support Session, Feb. 16th. Session is tailored to those diagnosed with or suspected of having Polymyositis,...
Myositis Patient Video Support Session, Feb. 6th. Session is tailored to those diagnosed with or suspected of having Polymyositis,...
Myositis Patient Video Support Session, Jan. 19th. Session is tailored to those diagnosed with or suspected of having Polymyositis,...
Myositis Patient Video Support Session, Jan. 9th. Session is tailored to those diagnosed with or suspected of having Polymyositis,...
Patients diagnosed with Polymyositis, Dermatomyositis, Necrotizing Autoimmune Myopathy, Juvenile Myositis, and other unspecified or nonspecific idiopathic inflammatory myopathies (myositis),...
Corbus launches DETERMINE, a Phase 3 trial of lenabasum for the treatment of dermatomyositis
, , Dermatomyositis, Featured, News
Corbus launches DETERMINE, a Phase 3 trial of lenabasum for the treatment of dermatomyositis. Double-blind, randomized, placebo-controlled, efficacy and...
Myositis and Cancer: Risk highest for carriers of anti-TIF1 antibody
, , Dermatomyositis, Featured, News
The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
Patients diagnosed with Polymyositis, Dermatomyositis, Necrotizing Autoimmune Myopathy, Juvenile Myositis, and other unspecified or nonspecific idiopathic inflammatory myopathies (myositis),...
During Myositis Awareness Month, May 2018, we placed a large focus on patient education by hosting some of the...
Myositis Patients, Join us for our Myositis Patient Live Video Support Session on November 17, 2018, starting at 2PM...
Patients diagnosed with Polymyositis, Dermatomyositis, Necrotizing Autoimmune Myopathy, Juvenile Myositis, and other unspecified or nonspecific idiopathic inflammatory myopathies (myositis),...
EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
, , Featured, News
Clinical trials and studies require patient groups in clearly defined categories, but the multiple diagnostic and classification criteria used...
Myositis patients, join us Saturday, October 20th at 2 PM Eastern for our live, online video support session. Meet...
Myositis patients, join us Thursday, October 11th at 7 PM Eastern for our live, online video support session. Meet...
Join us for our free Myositis Laughter Yoga Video Activity Session with Laughter Yoga Instructor Lynn Lizarraga. Laughter is...
Myositis patients, join us Saturday, September 22nd at 2 PM Eastern for our live, online video support session. Meet...
Dermatomyositis Patients with a Certain Type of Autoantibodies at Higher Risk of Skin Eruptions with Use of Hydroxychloroquine
, , Featured, News
In this study, the researchers set out to determine if there was a distinction between the type of autoantibodies...
Today, Corbus Pharmaceuticals announced that the European Commission has approved orphan designation for lenabasum in the treatment of dermatomyositis...
Our New Look
-
Inclusion Body Myositis Functional Rating Scale (IBMFRS) January 14, 2019
-
Inclusion Body Myositis Specialty Clinic at Washington University, St. Louis January 10, 2019
-
The first step when approaching a patient with muscle weakness – Differential diagnosis of idiopathic inflammatory myopathies in adults January 9, 2019
Upcoming Events
-
IBM Patient Video Support Session, January 2019
January 25 @ 4:00 pm - 5:30 pm EST
